Firocoxib for Mules: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Firocoxib is a prescription nonsteroidal anti-inflammatory drug (NSAID) in the coxib class. It works by selectively inhibiting cyclooxygenase-2, or COX-2, an enzyme involved in pain and inflammation. In horses, FDA-approved firocoxib products such as Equioxx are labeled for control of pain and inflammation associated with osteoarthritis for up to 14 days. It is available as oral paste, tablets, and an injectable equine form used by veterinarians.

For mules, firocoxib use is generally extra-label, which means your vet may prescribe it based on their medical judgment rather than a mule-specific FDA label. That matters because donkeys and mules can handle some drugs differently than horses. Published pharmacology reviews note that mules and donkeys have species-specific differences in drug absorption, metabolism, and elimination, so horse directions should not be copied over without veterinary oversight.

In practical terms, firocoxib is often considered when a mule needs anti-inflammatory relief but your vet wants a more COX-2 selective NSAID option. That can be useful in some chronic orthopedic cases, but it does not make the drug risk-free. Like other NSAIDs, it can still affect the gastrointestinal tract, kidneys, liver, and hydration status.

Because firocoxib is highly protein-bound and has a relatively long half-life in horses, it can build up over several days. Your vet may recommend baseline bloodwork and follow-up monitoring, especially if your mule is older, dehydrated, has a history of ulcers, or is taking other medications.

In equine medicine, firocoxib is used most often for pain and inflammation associated with osteoarthritis. Your vet may also consider it for other inflammatory musculoskeletal conditions where an NSAID is appropriate, such as chronic joint soreness, some back or soft tissue pain problems, or recovery periods where ongoing inflammation control is needed.

For mules, the most common real-world reason your vet may discuss firocoxib is longer-lasting daily pain control for stiffness, reduced comfort with work, or age-related joint disease. Some clinicians also choose it when they want to avoid certain tradeoffs of less selective NSAIDs, although every NSAID has its own risk profile and no option is right for every patient.

It is important to know what firocoxib is not for. It is not a substitute for diagnosing the cause of lameness, and it should not be started without a veterinary exam if your mule has acute severe pain, fever, colic signs, dehydration, or sudden non-weight-bearing lameness. Those situations need a clear diagnosis first.

If your mule is a food-producing animal or could enter the food chain, tell your vet before any dose is given. Equine firocoxib labeling states the product is not for horses intended for human consumption, and extra-label drug use in food animals raises additional legal and withdrawal-time concerns that your vet must address.

Always follow your vet's instructions. There is no mule-specific FDA-approved dose for firocoxib, so veterinarians commonly start from equine labeling and then adjust based on the individual mule, body weight, response, hydration, and lab work. In horses, the labeled oral dose is 0.045 mg/lb (0.1 mg/kg) by mouth once daily for up to 14 days. The horse tablet label also states that one 57 mg tablet is used once daily for horses weighing 800 to 1300 pounds.

That equine information is helpful, but it should not be treated as a do-it-yourself mule dose chart. Reviews of donkey and mule pharmacology emphasize that these animals can process drugs differently from horses, and direct extrapolation requires close monitoring for both underdosing and side effects. Your vet may also choose a different NSAID, a shorter course, or a different monitoring plan depending on the reason for treatment.

Firocoxib can be given with food if your mule tolerates that better. In horses, the oral paste syringe is marked by body weight, and the tablet form may be easier for some pet parents to give. Because the drug has a long half-life in horses, steady-state levels are reached only after several daily doses. That means improvement may build over a few days rather than after a single dose.

Do not combine leftover horse paste, dog chewables, or compounded products on your own. Dog-labeled firocoxib products use a very different dose, and formulation swaps can create dosing errors. If a dose is missed, contact your vet for guidance rather than doubling the next dose.

Like other NSAIDs, firocoxib can cause digestive upset and, in more serious cases, ulceration or organ injury. Mild problems may include reduced appetite, loose manure, diarrhea, mild lethargy, or behavior changes. In equine field studies with oral firocoxib, reported adverse reactions included diarrhea, loose stool, and excitation, while the client information warns that signs of NSAID intolerance can include oral erosions or ulcers, weight loss, colic, diarrhea, or icterus.

More serious concerns include mouth ulcers, worsening dehydration, kidney injury, and liver problems. Product safety data in horses found treatment-related oral ulceration and kidney lesions at higher or prolonged exposures, and the oral paste label notes toxicity was seen when treatment at the recommended dose extended beyond 30 days. That is one reason the labeled equine course is limited to 14 days unless your vet has a specific extra-label plan and monitoring strategy.

Call your vet promptly if your mule stops eating, seems depressed, develops colic signs, has diarrhea that lasts more than a day, drinks or urinates more than usual, shows yellowing of the gums or eyes, or develops sores on the lips, tongue, or gums. These can be early warning signs that the medication is not being tolerated well.

See your vet immediately if your mule is weak, severely dehydrated, has black or bloody manure, persistent colic, marked swelling, collapse, or a sudden major change in urination. NSAID reactions can become serious quickly, especially in older animals or those with hidden kidney or liver disease.

The most important interaction is with other anti-inflammatory drugs. Firocoxib should not be combined with another NSAID such as phenylbutazone, flunixin, ketoprofen, or aspirin unless your vet has given a specific plan. It also should not be used at the same time as corticosteroids such as dexamethasone or prednisolone. Combining these drugs can sharply increase the risk of gastrointestinal ulceration, bleeding, and kidney injury.

The equine tablet labeling also advises considering an appropriate washout period when switching from one NSAID to another NSAID or corticosteroid. That is especially important in mules, where species-specific pharmacology can make drug carryover harder to predict. If your mule has recently received bute, Banamine, or steroids, tell your vet the exact drug, dose, and date.

Use extra caution with medications that can affect kidney blood flow, hydration, or protein binding. General veterinary references list potential concerns with diuretics, ACE inhibitors, and some highly protein-bound drugs. The equine label notes that concomitant use of protein-bound drugs has not been studied in horses and that drug compatibility should be monitored when adjunctive therapy is needed.

Before starting firocoxib, give your vet a full list of everything your mule receives, including ulcer medications, supplements, joint products, herbal blends, and any recent injections. That helps your vet choose the safest option and decide whether bloodwork, urinalysis, or a different pain-control plan makes more sense.